Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rev Soc Bras Med Trop ; 35(6): 547-50, 2002.
Artigo em Português | MEDLINE | ID: mdl-12612733

RESUMO

Ten patients with chronic Chagas' disease were treated with nifurtimox (8-9 mg/kg/day) associated with betamethasone (9 mg/day initially and then gradually reduced) during 60 days, with one exception. It was intended to combine the respective anti-parasitic and anti-inflammatory actions of these drugs. The expected stimulating effect of betamethasone on the infection could possibly enhance the anti-Trypanosoma cruzi action of nifurtimox. Long term persistence of negative xenodiagnosis, used to control the results, was observed in only one of the cases. Regaridng the other patients, post-treatment positivity of xenodiagnosis and serological testes attested the failure of this therapy. As this study has demonstrated, adequate and long term follow-up of treated cases is necessary to ensure correct conclusions.


Assuntos
Betametasona/uso terapêutico , Doença de Chagas/tratamento farmacológico , Glucocorticoides/uso terapêutico , Nifurtimox/uso terapêutico , Tripanossomicidas/uso terapêutico , Adulto , Animais , Doença de Chagas/diagnóstico , Doença Crônica , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Xenodiagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA